Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 08:00 AM Eastern Daylight Time CHICAGO & NEW YORK--(BUSINESS WIRE)--Cardio Diagnostics, Inc. ('Cardio Diagnostics' or the 'Company'), a pioneering precision cardiovascular medicine company, and Mana Capital Acquisition Corp. (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR) ('Mana'), a special purpose acquisition company ('SPAC'), today announced that they have entered into a definitive business combination agreement that will result in Cardio Diagnostics becoming a publicly listed company.



Upon closing of the transaction, Mana will be renamed Cardio Diagnostics Holdings, Inc.
